DCAT Week is the premier global event held each year in New York City for companies engaged in the Bio/Pharmaceutical manufacturing value chain. is a subsidiary of Porton that specializes in providing contract chemistry services to the biopharmaceutical and biotechnology industry. We develop efficient catalytic reactions and reaction processes by utilizing the newest tools together with verified experimental techniques, scientific and In solid-dosage processes, the API is generally blended with excipients via wet or dry granulation. 3. The incumbent should provide the expertise in the scaleup requirements of flow chemical processes and manufacturing process development. Our experience across a wide, cross-functional field guides J-Star Research scientists to the best design strategy. J-Star Research reduced the number of steps in one client’s process from 11 steps to 3, bringing the cost of goods from >$500,000 down to <$7,500 per kg! In addition to these cost savings, our improved process also dramatically the shortened time cycles needed to prepare the API. We are very excited to announce the technical program of Pharma Crystallization Summit 2022. With the help of our strength in formulation design and characterization of new drug candidates, our expertise covers the aspects of early drug product development including the preformulation studies and formulation, and process development of novel dosage forms. Welcome to our Employment section; Diversity and Inclusion Jun 14, 2020 · Dr. (973) 267-7373. SAPA ANNUAL CONFERENCE is a great platform for participants to share knowledge, wisdom, and viewpoints on important issues and current trends in academic research and pharma and biotech industries. The primary role responsibility is to perform scale-up of flow chemical reactions, process development, optimization, scale-up and manufacturing in support of J-Star’s Enabling Technologies projects. 1st 2020 as Senior Vice President, Business Development, with a focus on developing deeper relationships with large pharmaceutical clients in North America and Europe throughout the development cycle. 1%) of impurities in chemical intermediates and APIs. The primary responsibility in this role is to perform Home » Contract Research & Development » Drug Product Development » Technology Demonstration and Feasibility The Focus and Expertise to Perfect Formulation and Development The quality and experience of our scientists - most with a background in "Big Pharma" - gives us the ability to deploy innovative solutions at a cadence unrivaled in the CRO Mar 27, 2020 · J-Star Research has recently established significant impurity isolation and structural elucidation capabilities. J-Star Research, Inc. Crystallization technologies are bridges between drug substances and drug products enabling consistent safety and efficacy profiles of small molecule based medicines. Compare pay for popular roles and read about the team’s work-life balance. ACS Journal Subscription Hard Copies - ACS Web and Backfiles Elsevier Science Direct Corporate Research Chemist with MS degree in Chemistry, Chemical Engineering or related field with 6 months of research experience wanted for J-Star Research, Inc. J-STAR is focused on providing high standards in Quality Assurance in every aspect of the cGMP synthesis and manufacturing process. The new building is projected to open in Q4 of 2022. Miao brings with her more than 25 years of experience in technical, operational, and strategic leadership within the pharmaceutical industry as she will navigate Porton’s overall business At J-STAR Research, we have the ability to quickly forward your formulation to our parent company (Porton Pharma Solutions Ltd. J-STAR scientists have already characterized the physical and chemical properties of MTX-101 to ensure formulation and process development can be conducted. Scientists at J-STAR are assigned to each project based on the anticipated demands of the project and their expertise. Quality Assurance. is a leading R&D services provider focusing on drug substance and drug product developments from pre-IND to commercialization. The outcome of those experiments then guided the J-Star Research is pleased to announce our collaboration in the 3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series, featuring an impressive line-up of speakers and topics. from the people who know best. 2/5 stars. Jul 28, 2022 · Porton is excited to announce construction of a new, state-of-the-art Crystallization and Drug Product facility in Cranbury, NJ. Pressures of up to 100 psi. Discuss Your Project with a Scientist Home » History » Chemical Information Library Subscriptions The company has subscriptions to SciFinder for on-line searching and maintains subscriptions to numerous chemistry journals with on-line access. © 2023 J-STAR Research, Inc. Andrew Thompson, formerly of Merck Research Laboratories, J-Star has become a leading provider of services in Complex Organic Synthesis, Process Research and Crystallization Jan 27, 2017 · CRANBURY, N. Each webinar will. , cocaine, methamphetamine Jan 2, 2023 · Find out what works well at J-Star Research, Inc. (“J-STAR”, “Company”, “we or “us”) is a contract chemistry organization serving as an outsourcing partner for the biopharmaceutical and biotechnology industry. J-STAR is a leading provider of services in J-Star Research is a contract research organization providing services to pharmaceutical and biotechnology industries. Synthetic Route Design; Catalysis & Enabling Technology; High Star research is an Peer-reviewed International online journal. DCAT Week is not a Trade Show. In effort to fully utilize existing tools and develop better methodologies for solving bottleneck problems in new drug development programs, the annual Pharmaceutical Crystallization Summit gathers leading Schedule a meeting to talk with us about: Developing your target molecule. Cactus Life Sciences Business Consulting and Services Princeton, New Jersey J-Star Research, Inc. All projects at J-Star are managed by highly experienced scientists from the pharma industry. Jun 7, 2022 · J-STAR Research is a contract development organization, serving as an outsourcing partner for the pharmaceutical and biotechnology industries. jstar-research. We have decades of consistent records providing J-Star Research, Inc. SAPA Annual Conference. Mar 10, 2020 · J-STAR Research, Inc. This fundamental material knowledge forms the basis of our Quality by Design (QbD) approach to improving History of J-Star Research Menu Toggle. is a contract chemistry organization serving as an outsourcing partner for the pharmaceutical and biotechnology industries. This J-Star Research auxiliary facility occupies 37,000 square feet of leased space in Cranbury, NJ. Temperatures of -50°C to 150 °C. Come visit J-STAR Research at booth #923 from May 17-19 at the Pennsylvania Convention Center! Add to calendar. Identifying a problematic impurity. In the past 3 years, more than 150 single crystal structures have been elucidated in support of fast-paced new drug development programs. Welcome to our Employment section; Diversity and Inclusion J-STAR Research, Inc. Sc, Ph. AAPS provides a dynamic forum for the exchange of knowledge among scientists to enhance their contributions to public health through its many meetings that offer timely scientific programs About Menu Toggle. (hereafter referred to as J-star) is an innovative CRO serving as an outsourcing partner for the pharma and bio industries. , Jan. g. ("J Jul 21, 2022 · July 21, 2022 | Center for Pharma Crystallization, News & Events. Using up to 24-cores/48-threads and 192GB of RAM, the computational resources at J-Star Research provides a wide range of capabilities. Andrew Thompson, formerly of Merck Research Laboratories, J-Star has become a leading provider of services in complex organic synthesis and crystallization for a variety of J-Star Research, Inc. This year’s Summit is in-person only and the seats are limited. Andrew Thompson, formerly of Merck Research Laboratories, J-Star has become a leading provider of services in Complex Organic Synthesis, Process Research and Crystallization J-Star Research, Inc. sensitivity gain over a room-temperature probe of up to 4X. J. a Pharmaceutical CRO specializing in small molecule, Crystallization R&D, cGMP API manufacturing, High Potency. are excited to be exhibiting at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting at the Boston Convention Center on October Below are some of the flow capabilities at J-star: Plug flow reactors with overall flow rates of 0-20 mL/min. The results of these studies are used to determine the retest interval for an Active Pharmaceutical Ingredient (API) and dictate the shelf life for a drug product. (J-Star) and XtalPi will be hosting the 2020 Pharmaceutical Crystallization Summit on October 7th and 8th, 2020, online (live). An Integrated Approach to Process Development. View Organizer Website. in Cranbury, NJ to: perform API crystallization process in compliance with cGMP and FDA regulations, utilizing analytical tools including chromatography, separation, and solvent selection; support crystallization process development by J-Star research, Inc. is a Contract Development and Manufacturing Organization (CDMO) focusing on drug substance and drug product development and optimization. We are proud to offer our employees the following benefits: We are proud to offer our employees the following benefits: Jul 7, 2020 · Porton Pharma Solutions Welcomes Dr. work email addresses. 4023. Continuous Stirred Tank Reactors (CSTRs) of 5-500 mL volume. Joanne Johnson joined JSTAR Research, Porton USA on Feb. Optimal operating ranges are determined using best engineering practices. EVENT TOPICS: • Plenary sessions featuring distinguished scholars and leaders to showcase the latest trend of the pharma development; • Legal and Regulatory Issues, Challenges, and History of J-Star Research Menu Toggle. J-Star’s systems are based on recent reactor design and are validated for mixing and heat-transfer properties. For purposes of this Notice Jun 26, 2020 · J-STAR Research, Inc. These protocols are available to be reviewed by the Stability Studies: GMP and non-GMP. Traditionally, one (or several reactions) were run at a time. Phone. (J-Star) and XtalPi will be hosting the 2020 Pharmaceutical Crystallization Summit on October 7th and Oct 18, 2020 · Crystallization technologies are bridges between drug substances (DS) and drug products (DP) enabling consistent and robust safety and efficacy profiles of small molecule based medicines. and J-STAR Research, Inc. Date range: 1 March 2023 - 29 February 2024 No articles found. Oliver will present “Contract Organizations: from Outsourcing Partner to Infrastructure in the Industry History of J-Star Research Menu Toggle. Synthetic Route Design; Catalysis & Enabling Technology; High The most common J-STAR Research, Inc. Our integrated solutions offer a unique set of services for new drug candidates from drug discovery to drug product development for preclinical and clinical studies. (hereafter referred to as J-star) is an innovative CRO serving as an outsourcing partner for the Pharmaceutical Industry. We cordially invite CMC leaders/managers of drug development programs, API crystallization experts or solution providers DCAT Week. Welcome to our Employment section; Diversity and Inclusion; CA Job Applicant Notice; CA Employee Notice; Contract R&D Menu Toggle. The R&D team is comprised of experts in identifying and characterizing low levels (e. SOUTH PLAINFIELD, N. Retention Markers These are typically starting materials, impurities, intermediates, and drug substances used qualitatively in test methods to mark retention times and identify peaks, as components of mixtures to Aug 6, 2020 · J-STAR Research & XtalPi Host 2020 Pharmaceutical Crystallization Summit SOUTH PLAINFIELD, N. (“ Company ”, “ we ”, “ us ” and “ our ”) collects about our employees who are California residents, and the purposes for which we use that information. 452. Founded in 2005, Porton Fine Chemicals is a top-tier, China-based external manufacturing partner If you would like to contact us regarding the accessibility of our website or need assistance completing the application process, please call (844) 565-7827 ext. Other common J-STAR Research, Inc. com), which is being used by 80. Must have knowledge of FDA regulations, Polymorph characterization Thinkers & Doers. 1 2 This approach combines two Jun 19, 2023 · Join us in welcoming Dr. 201. Reducing barriers to manufacturing. Over time, I have come to specialize in troubleshooting difficult reactions and work-up procedures. We can partner with you to design and execute a research operating plan so that the scope of synthetic route design is integrated into your J-Star Research | 103 followers on LinkedIn. Schedule a meeting to talk with us at 2023 Pharma ChemOutsourcing ChemOutsourcing will take place in Parsippany, New Jersey on September 6-8, 2023! More About the 2023 Show: ### ChemOutsourcing is the largest USA-based API and Pharmaceutical Ingredients Sept show attracting Aug 7, 2020 · Share this article. It is the process through which experts in the field of study assess the quality of articles that are submitted to a journal for publication. Email. Porton Pharma Solutions Ltd. This facility will be cGMP capable for Drug Product supplies, and will expand our ability to offer integrated Drug Substance (DS) and Drug Product (DP) R&D. Contract Research Organization (CRO): A trusted chemistry partner to leading pharmaceutical and biotechnology companies. email format is [first_initial][last] (ex. About Porton. Synthetic Route Design; Catalysis & Enabling Technology; High History of J-Star Research Menu Toggle. J-STAR Research, Inc. PORTON’s manufacturing activity in the Life Science Park Mengeš will be J-Star Research, Inc. This contact information is for accommodation requests only and cannot be used to inquire about the status of applications. Wenfang Miao as CEO of J-STAR Research, Ushering in a New Era of Pharmaceutical Innovation June 19, 2023 Porton Pharma Solutions Launches State-of-the-Art Small Molecule Platform in Shanghai, Elevating CDMO Services Mar 17, 2022 · J-Star Research is pleased to announce our collaboration in the 3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series, featuring an impressive line-up of speakers and topics. , a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API facility inside, Life Science Park Mengeš, Slovenia currently owned and operated by Lek Pharmaceuticals d. About Menu Toggle. 7 likes. +1. It specializes in API synthesis and crystallization. Andrew Thompson, formerly of Merck Research Laboratories, J-STAR Research, Inc. J-Star Research’s high-pressure capabilities combine the best of reactor design, reaction engineering and 1 st principle understanding. Our integrated solutions offer a unique set of services for the new drug candidates from drug discovery to drug product development for preclinical and Phase I clinical studies. Optimizing your current synthetic process. is a contract chemistry organization serving as an outsourcing partner for the biopharmaceutical and biotechnology industry. 0% of J-STAR Research, Inc. Stability studies are typically initiated with material produced from Aug 12, 2022 · PORTON PHARMA SOLUTIONS LTD. ) for large-scale, multi-kilo GMP, but if you prefer stay local, we also have many national partners with robust commercial capacity we collaborate with on a regular basis. Synthetic Route Design; Catalysis & Enabling Technology; High Learn more about J-STAR Research, Inc. 7, 2020 /PRNewswire/ -- J-STAR Research, Inc. Founded in 1996 by Dr. Research Scientist wanted for J-Star Research Inc in Cranbury, New Jersey, with Master’s degree in Chemistry, Chemical Engineering, or Materials Science and Engineering, and at least one year of experience in the pharmaceutical industry. Thus, we can effectively address issues affecting formulation early in Phase I. AAPS provides a dynamic forum for the exchange of knowledge among scientists to enhance their contributions to public health through its many meetings that offer timely scientific programs, on-going education, information resources, opportunities for networking, and professional development. Our primary focus is resolving intricate chemistry problems relating to Active Pharmaceutical Ingredients and Intermediates in the preclinical and clinical development phases. J-STAR Research Inc. By J-Star Research | September 2, 2022. com). jdoe@jstar-research. J-STAR Research employees rate the overall compensation and benefits package 3. 0. data collection time reduction of 20X. Schedule to meet with J-STAR Research at DCAT Week 2022. , and Vice-President of Porton Pharma Solutions, LTD. To fully utilize existing tools and develop better new methodologies for solving bottleneck problems in new drug development, the Center for Pharma Crystallization at J-Star Research launches its first annual conference, jointly J-STAR Research, Inc. Andrew Thompson, formerly of Merck Research Laboratories in the Department of Process Research, J-STAR Research, Inc. Our integrated teams of subject matter experts (SMEs) across synthesis, crystallization, formulation, analytical and GMP delivery have been effectively debottlenecking drug development programs. 4 Walk in Kilo lab Walk-in Hoods with up to 100 L Vessel Processing. Mar 12, 2020 · South Plainfield, NJ. operates as a contract research organization for pharmaceutical and biotechnology companies worldwide. The new site features a streamlined, modern design, improved functionality, and easy access to essential information to help J-STAR Research, Inc. Applying over 160 years of cumulative experience in Big Pharma, our subject matter R&D Center 2: Cranbury, NJ. is the best company for you. . J-STAR is a leading provider of services in Jobs & Careers at J-STAR Research, Inc. March 20, 2022 - March 24, 2022. Joanne obtained her B. It offers services in the areas of custom synthesis/contract research, process and analytical research, cGMP synthesis, crystallization process development, solid form screening and selection, pre/early formulation, and drug substance-drug product coprocessing. Nov 5, 2020 · Author: J-Star Research. com. 3001 Hadley Road, Suites 1-5; South Plainfield, NJ 07080 (609) 860-1300 Visit Website Facebook; Twitter; Linkedin; Get Directions Current Hours J-STAR Research, Inc. d. Method verification / validation protocols are prepared following a phase-appropriate strategy informed by the J-STAR in-house SOP, written according to ICH Q2 guidance and current USP Chapters <1225> and <1226>. C. Wenfang Miao (Renee) as the new CEO of Porton USA, L. The ability to bridge the DS/DP interface is a major competitive advantage, and Jun 6, 2024 · The average J-STAR Research salary ranges from approximately $66,193 per year (estimate) for a Process Chemist to $186,220 per year (estimate) for a Senior Principal Chemist. J-Star Research is pleased to announce our collaboration in the 3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series, featuring an impressive line-up of speakers and topics. , a subsidiary of Porton Pharma Solutions Ltd. , Aug. Streamlining your supply chain. Introduction. · Experience: J-STAR Research, Inc. Process Chemistry R&D Menu Toggle. Effective Date: June 13, 2023. Research Scientist. (“ Company ”, “ we ”, “ us ” and “ our ”) collects about California residents who apply or are recruited for a job with us (“ candidates ”), and the purposes for which we use May 12, 2021 · By cooling the detection coil and the preamplifier to near absolute-zero temperature, this new capability will provide the following advantages in support of J-Star’s structural elucidation group: NMR background noise greatly improved. History of J-Star Research Menu Toggle. D. By J-Star Research. Welcome to our Employment section; Diversity and Inclusion Jobs & Careers at J-STAR Research, Inc. With the ability to develop both Drug Substance (DS) and Drug product (DP) under the same umbrella, our team enjoys a synergism absent in most CROs. Systems compatible with corrosive chemicals. Location: New York, NY. Contract Research & Development. The journal is aimed to publish original ideas of empirical and research papers that will contribute to the knowledge of the readers and add The strategic acquisition will complement Porton’s recently launched Process Technology Center in Cranbury, NJ and adds J-STAR’s expertise and technologies onto more comprehensive, integrated development services to more customers. 27, 2017 /PRNewswire/ -- Porton Fine Chemicals, Ltd. Co-processing is a relatively new area of particle engineering in which commonly used excipients can be combined with the API in a more deliberate and controlled manner to design a pharmaceutical composite material. Dedicated quality assurance personnel ensure that documentation and records, SOP’s and laboratory controls are maintained. J-Star Research and Porton Pharma Solutions Ltd. Bridging the Drug Substance and Drug Product Interface. J-Star Research scientists divide reference standards into two groups: Retention Markers and Quantitative Reference Standard. is committed to assisting employees maintain a healthy and productive lifestyle for themselves and their families. L. Our services in Catalysis and Enabling Technology are differentiated through our integrated approach in the overall process development. , South Plainfield, New Jersey. J-Star Research has a wide range of capabilities using different DoE software packages. This notice (“ Notice ”) describes the categories of personal information that J-STAR Research, Inc. Some typical factors impacting the choice of strategy used and the designs are: J-Star’s team of 50 PhD process chemists have an impressive track record of designing cost effective and efficient synthetic routes to target molecules in support of the biopharmaceutical industry. 's jobs, projects, latest news, contact information and geographical presence. , ("Porton", SZ 300363), a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, today announced that Porton USA, L. A partial listing of some of our Analytical Instrumentation and Specialized Equipment is given below: 34 Fume Hoods in multiple laboratories. did not contribute to any primary research papers from Nature Index journals in the current 12 month window. Dr. Facilities; Chemical Information Library; Resources; Careers Menu Toggle. ), CTO of Porton/J-Star Research, will be Keynote Speaker and CMC Speaker, respectively, at this year’s Sino-American Professionals Association (SAPA) Annual Conference on October 2. is a contract chemistry organization serving as an Oct 24, 2023 · About Menu Toggle. , part of NOVARTIS group. This is achieved through our focus on our quality systems management. provides CRO & CDMO services to the pharmaceutical industry including Crystallization R&D, drug formulation & GMP Phase 1 Clinical Supply. Our goal is in line with our client’s goal to make Jun 19, 2023 · AAPS Annual Meeting at the Boston Convention Center on October 16th – 19th. to Showcase Expanded Capabilities at BOS BASEL 2023 in Switzerland. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. ("PTC"), a wholly-owned subsidiary of Porton, has entered into a stock purchase agreement with the shareholders of J-STAR Research, Inc. ICH Stability Studies are a critical part of the drug development process. Discuss Your Project with a Scientist J-STAR Research's State-of-the-Art facilities are fully equipped & licensed to meet common, critical needs, including: Controlled Substances (DEA Schedule II-V) J-STAR’s South Plainfield facility is registered with the DEA as a research Using these predictions, J-Star Research scientists can gain deeper mechanistic insight, rationalize experimental observations, and identify improved strategies and routes towards their targeted molecules. Experienced Director Health Safety with a demonstrated history of working in the… · Experience: J-Star Research · Education: Montclair State University · Location: Matawan · 312 connections J-STAR Research, Inc. Date: March 21-24, 2022. doe@jstar-research. J-STAR's South Plainfield facility is registered with the DEA as a research facility for the following schedules: DEA Schedule II-V Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence, e. postdoctoral experience in the UK working in bio AAPS 2023 PHARMSCI 360. October 22, 2023 - October 25, 2023. Publish Date: 2020-11-11 18:15:01. This is done by impurity enrichment from mother liquors, impurity isolation from process streams or by mass directed semi-preparative HPLC In recent years, High-Throughput Experimentation (HTE) - in which 100 or more experiments are conducted in parallel - has emerged as an important tool for the pharmaceutical industry at various stages of drug discovery and development. , March 12, 2020 -- J-Star Research, Inc, the leading Contract Research Organization focused on Small Molecule Process Research and Crystallization R&D, is proud to announce the launch of its newly redesigned website at https://www. Headed by world class scientists, the Center for Pharma Crystallization (CfPC) is a recognized industry leader in solid form studies, crystallization process development, pre-formulation evaluation, particle engineering and DS-DS co-processing. Our focused approach ensures the delivery of high quality solutions and materials in a timely fashion. This is a 4-week webinar series with a webinar every Wednesday from April 6 to April 27 organized by XtalPi and J-Star Research, Inc. J-Star Research has frequently been able to fix processes and About. · Education: University of Pittsburgh · Location: New M]Method verification / validation occurs prior to the subsequent GMP delivery. a Pharmaceutical CRO specializing in small molecule, Crystallization R&D, cGMP API manufacturing, High Potency Sep 21, 2021 · We are proud to announce that Porton’s Chairman and CEO, Niafeng (Oliver) Ju (EMBA), and San Kiang (Ph. You can get professional help from our leading crystallization expert with decades of successful experiences from BMS and the Center for Pharma Crystallization (CfPC) at J-Star Research. is an equal opportunity employer. email patterns are [last] (ex. Crystallization technologies are bridges between drug substances (DS) and drug products (DP) enabling consistent and robust safety and efficacy profiles for small molecule-based medicines. Uncover why J-Star Research, Inc. J-Star’s Drug Product Development division has developed technology platforms able to optimize API powder properties and improve aqueous dissolution as needed. sr zm iw sj qa jh vw jm xv lx